Pakar Kista

Cyst Health, Explained

Breaking News
FDA Approves First-in-Class Pancreatic Cancer Therapy
Cyst Risks

FDA Approves First-in-Class Pancreatic Cancer Therapy

FDA approves Rasonque, the first-in-class pancreatic cancer therapy targeting RAS mutations. Learn how this new oral treatment works for metastatic cancer.

By Aurel Maulana Aug 27, 2026

Cyst Risks

View All

Cyst Types

Living With Chronic Cancer A Long-Term Struggle
Cyst Types

Living With Chronic Cancer A Long-Term Struggle

Chronic cancer forces patients and families to adapt to ongoing treatment, lifestyle changes, and emotional resilience, offering a new definition...

By Aurel Maulana Aug 31, 2026

Diagnosis Guides

View All

Ovarian Health

All Stories

Treatment Options

All Stories

All Post

FDA Approves BESREMi, Offering New Essential Thrombocythemia Options

FDA Approves BESREMi, Offering New Essential Thrombocythemia Options

By Salsabila Hartanti September 1, 2026
FDA approves BESREMi, a new treatment for essential thrombocythemia, providing fresh options for patients with this rare blood cancer.
Living With Chronic Cancer A Long-Term Struggle

Living With Chronic Cancer A Long-Term Struggle

By Aurel Maulana August 31, 2026
Chronic cancer forces patients and families to adapt to ongoing treatment, lifestyle changes, and emotional resilience, offering a new definition of hope.
New Treatment Boosts Survival in Biliary Cancer

New Treatment Boosts Survival in Biliary Cancer

By Aurel Maulana August 30, 2026
Ivonescimab boosts survival in biliary cancer with improved overall survival rates compared to Imfinzi.
Metastatic Breast Cancer Symptom Awareness for Patients

Metastatic Breast Cancer Symptom Awareness for Patients

By Trisna Anggraini August 29, 2026
Learn about metastatic breast cancer symptoms and awareness for patients to identify changes sooner and contact their cancer care team effectively.
Oncologist Details Qaseq Approval Impact

Oncologist Details Qaseq Approval Impact

By Salsabila Hartanti August 28, 2026
Rasonque (daraxonrasib) approved for metastatic pancreatic cancer, offering new hope and extended survival. Learn from Dr. Kristin Higgins, radiation oncologist
FDA Approves First-in-Class Pancreatic Cancer Therapy

FDA Approves First-in-Class Pancreatic Cancer Therapy

By Aurel Maulana August 27, 2026
FDA approves Rasonque, the first-in-class pancreatic cancer therapy targeting RAS mutations. Learn how this new oral treatment works for metastatic cancer.
FDA approves Ziihera combos for HER2-positive cancer

FDA approves Ziihera combos for HER2-positive cancer

By Trisna Anggraini August 26, 2026
HER2 positive cancer patients receive new options as the FDA approves Ziihera combos for HER2‑positive gastroesophageal cancer, expanding therapies.
New advances in lung cancer treatment options

New advances in lung cancer treatment options

By Salsabila Hartanti August 25, 2026
Explore the latest lung cancer treatment options, including immunotherapy and targeted therapy. Learn how these advanced treatments work and manage side effects
Three Lung Cancer Treatments and How They Work

Three Lung Cancer Treatments and How They Work

By Trisna Anggraini August 25, 2026
Learn how lung cancer treatment works with chemotherapy, targeted therapy, and immunotherapy. Discover mechanisms, side effects, and management tips from an exp
Oncology Nurse Stays by Patient Until His Final Days

Oncology Nurse Stays by Patient Until His Final Days

By Aurel Maulana August 24, 2026
Discover the touching story of an oncology nurse who stays by a patient's side until his final days. Read Jill May's nomination for the CURE Extraordinary Heale
1 2 3 9
© 2026 Pakar Kista. All rights reserved.